Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Health

AstraZeneca-Daiichi breast cancer drug cleared for NHS use in England

Arab News

HealthArab News·Sep 17, 2026·1 min read

AstraZeneca-Daiichi breast cancer drug cleared for NHS use in England

LONDON: AstraZeneca and Daiichi ‌Sankyo said on Thursday their breast cancer treatment Enhertu has been approved for use in England’s state-run health care system, expanding access to a drug that has been available in Scotland since 2023…

View original source — Arab News ↗

ShareShare on X Share on Facebook

Related stories

New hope for breast cancer patients as life-extending drug now on NHS in England

HealthSep 16, 2026 · 1 min

New hope for breast cancer patients as life-extending drug now on NHS in England

Women in England with incurable breast cancer to get life-extending drug on NHS

HealthSep 17, 2026 · 1 min

Women in England with incurable breast cancer to get life-extending drug on NHS

Life-extending drug for breast cancer patients now on NHS

HealthSep 17, 2026 · 1 min

Life-extending drug for breast cancer patients now on NHS

GSK licenses Chinese firm’s cancer drug in US$750 million deal

South China Morning Post

HealthSep 16, 2026 · 1 min

GSK licenses Chinese firm’s cancer drug in US$750 million deal

South China Morning Post